ADAPT
SpecialtyADAPT is a specialty pharmaceutical company focused on Ophthalmology, Infectious Disease, Cardiovascular.
ADAPT's Key Drugs
ADAPT's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
ADAPT's Recent FDA Approvals
New NDA/BLA approvals for ADAPT over the last two years — novel drugs only, excluding generics and label supplements.
ADAPT's Therapeutic Areas
ADAPT's approved drugs and pipeline span 3 therapeutic areas, led by Ophthalmology and Infectious Disease. Weighted by commercial stage — approved drugs count most, then late-stage trials.
ADAPT's Top Competitors
ADAPT's closest competitors by therapeutic-area and drug-target overlap include Baxter, B BRAUN, and BAUSCH AND LOMB INC. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
ADAPT Pipeline Snapshot
ADAPT has 4 active clinical programs from ClinicalTrials.gov — 4 Phase 3, 0 Phase 2 and 0 Phase 1.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Ophthalmology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1971-04-13
- Latest
- 2002-10-25
- Applications
- 1